2017 EVIDENCE USA SPEAKERS

Rachel is a Director of Payer Policy and Health Outcomes on the Payer Relations and Reimbursement Team at Foundation Medicine. She leads the development of US HEOR initiatives and is focused on payer education about the unique clinical value of  comprehensive genomic profiling. Her professional...

Elise Berliner, Ph.D., is the Director of the Technology Assessment Program at the Agency for Healthcare Research and Quality (AHRQ). The Technology Assessment program provides technology assessments to the Centers for Medicare & Medicaid Services (CMS) to inform Medicare coverage decisions and ...

Ms. Bragg frequently represents pharmaceutical, medical device and food companies in crisis management situations related to products that have manufacturing or quality issues, helping them navigate the myriad of matters that arise in the context of product recalls, and also counsels on...

Dr. Brod received his medical degree from the University of Pennsylvania and completed his residency in Dermatology at the University of Pittsburgh after completing a one-year internship in Internal Medicine at Brown University. He was Board certified in Dermatology in 1991 and recertified in...

David Davidovic has been involved in the commercialization of products and in building best-in-class commercial capabilities in the pharmaceutical and biotechnology industries for over 37 years.  Most recently, David was Vice President and Global Head of Commercial Services for Roche and...

Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and...

Dr. Gaebler was Senior Director, Global Medical Outcomes Strategy at Biogen Idec, Inc., where she provided strategic leadership and technical expertise to ensure that global medical product strategies and tactics integrate the evolving demands of the global payer landscape. As Director, Global...

Bill GoodsonDirector, Market Access and Reimbursement ServicesEisai Dec 2015-Present: Director Market Access and Reimbursement Services – EisaiDec 2013-Dec 2015: Deputy Director Patient Access Services - BayerNov 2011-Nov 2013: Deputy Director Pricing and Reimbursement and Patient Assistance...

Since late 2013, Katherine Hempstead, PhD, has directed the Robert Wood Johnson Foundation’s work on coverage. In addition, Hempstead works on issues related to health care price transparency and value. She joined the Foundation in 2011 as a senior program officer in the Research and Evaluation...

Athula Herath, PhD, MBCS, CITP, CEngAthula Herath is the Global Head of Real World Evidence Epidemiology and affiliated with the Center of Excellence for Real World Evidence at Novartis. Prior to that, Athula worked for  10 years as Statistical Director for Medimmune/AstraZeneca. Athula joined...

Dr. Jonathan P. Jarow is currently the senior medical advisor to the Center Director in CDER at FDA.  Jonathan previously served as the director of CDER’s Office of Medical Policy, chair of the Medical Policy Council, and as deputy director of the Office of Hematology and Oncology Products.  He is...

Designed, implemented a data collection procedure and responsible for working with several Rare Patient Advocacy groups/non-profits/patients and Medical Institutions in the USA and Internationally to capture, aggregate and store all patient Institutional Medical Health Data. Compiled an...

Mr. Klein brings over 35 years of experience in health care and information technology services to the Patient Access Network (PAN) Foundation. Mr. Klein came to the PAN Foundation from the Cystic Fibrosis (CF) Foundation, where he served as Senior Vice President for the CF Services pharmacy and...

Mr. Koester is the Managing Partner, OHWK Business Management Advisory. His professional background includes extensive business management consulting experience to global pharmaceutical manufacturers in the functional areas of Canadian health technology assessment, price negotiations, market...

Currently leads the  Global Health Economics, Market Access and reimbursement Strategy at CSL Behring. In the past Lead US HEOR and epidemiology team at GSK to support Vaccines, And supported Diabetes and Metabolism at Merck portfolio at Merck and BMS

Christine Lu MSc, PhD is an Associate Professor in the Department of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and she co-directs the PRecisiOn Medicine Translational Research (PROMoTeR) Center. She is a pharmacist, health policy scientist and...

Bill Martin is the Chief Commercial Officer for Accredo. In this role, Mr. Martin is responsible forguiding the development and growth of the organizations overall specialty business with payers,pharmaceutical manufacturers, and distribution partners. He leads a team that is heavily focused...

John Maslowski serves as Fibrocell’s President & Chief Executive Officer. Previously, he was SVP of Scientific Affairs, with oversight of R&D, clinical and regulatory affairs, and formerly was VP of Operations with responsibility for manufacturing and quality operations. Prior to...

Michele McCourt is Senior Director of the CancerCare Co-Payment Assistance Foundation. In this role, Ms. McCourt has overall operational responsibility for the development of the foundation. With more than 27 years of experience in patient services, she has overseen the implementation of dozens of...

Responsible for leading Market Access BU including Pricing, Reimbursement, Health Economics, Government Affairs and Advocacy. Also Commercial strategies and activities.Master Degree in Pharmacoeconomic / Health EconomicsActed in the area of market access and pharmacoeconomics as independent...

Former:1) Senior staff member at Canadian Medical Association - Manitoba Division.  Negotiator for collective agreements, physician procedural fees, and private service agreements2) Executive Director, Manitoba Society of Pharmacists3) Public Affairs & Reimbursement, GlaxoSmithKlineCurrent:4)...

David B. Nash was named the Founding Dean of the Jefferson College of Population Health (JCPH) in 2008. This appointment caps a 25-year tenure on the faculty of Thomas Jefferson University.  He is also the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy.  JCPH provides innovative...

Ms. Niles oversees relationships/partnerships with patient advocacy and professional organizations, as well as the Foundation’s public advocacy initiatives.  Before joining the PAN Foundation, Ms. Niles served as Chair, Medical Relations and Advocacy for the Together Rx Access program. Prior to...

Nneka C. Onwudiwe, PhD, PharmD, MBA received her doctorate in Pharmacy (PharmD) from the University of Maryland School of Pharmacy, PhD in Health Services Research with a specialization in Pharmacoeconomics from the University of Maryland School of Pharmacy, and a MBA (Honors) from the University...

Melissa serves as the Oncology Patient Access Principal Coordinator at the Emily Couric Clinical Cancer Center, UVA Health System. She is responsible for patient access integration within the HCP and implementing all patient access programs across the spectrum, in the form of co-pay assistance...

Leena Patel oversees donor relations and development at the Patient Access Network Foundation. As the Director of Development, Ms. Patel maintains the day-to-day communications with PAN’s donors, and also maintains existing and identifying new disease fund opportunities. Prior to joining the PAN...

Edmund J. Pezalla, MD, MPHDr. Pezalla in a leading innovator and consultant on payer strategy for pharmaceutical and device manufacturers. He focuses on unlocking the value of new products by developing industry-leading approaches to incorporating payer requirements into development...

A career public servant, Tanya Potashnik possesses a breadth of knowledge in the area of pharmaceutical environment in Canada both from a provincial and Federal perspective. Tanya is currently the Director of policy and economic analysis at the Patented Medicine Prices Review Board. Prior to this...

Jason C. Simeone, PhD, MS, is an epidemiologist and Research Scientist in the Real-World Evidence group at Evidera in Waltham, Massachusetts. Dr. Simeone’s experience is focused in the areas of pharmacoepidemiology, drug safety, and outcomes research, and he serves as principal investigator or...

Dr. Jamie Skipper, RN, PhD, is currently a Healthcare/Health IT Policy Advisor and Strategist at Elevation Health Consulting where she advises public and private stakeholders across the healthcare arena to strategically improve health outcomes with a person-centric motto through...

Dr. Lotte Steuten is an entrepreneurial academic, striving to accelerate patient access to high-value healthcare innovations. She has deep expertise in health economics and evidence development that she applies to identifying and articulating the clinical, humanistic and economic value of medical...

Dr. Tang is the Senior Director and Head, Growth Markets of Global Health Economics and Outcomes Research (GHEOR) at Teva Pharmaceutical, responsible for health outcomes research in developing countries and Asia region. Dr. Tang has established the newly created Growth Markets Market Access and...

Meredith Wadman has covered biomedical research politics from Washington for twenty years. She is a reporter at Science and was formerly a reporter for Nature and a contributing writer at Fortune. Her opinion articles have appeared in the New York Times, the Washington Post and the Wall Street...

Surrey Walton, PhD, is an Associate Professor in the Department of Pharmacy Systems Outcomes and Policy and Assistant Director of the Center for Pharmacoepidemiology and Pharmacoeconomic Research. Dr. Walton was a founding member of the Center for Pharmacoepidemiology and Pharmacoeconomic Research...

Durhane Wong-Rieger, PHD is Chair of Rare Disease International (the global alliance of rare disease patient organizations), Past-Chair of the International Alliance of Patient Organizations, member of the Editorial Board of The Patient- Patient Centred Outcomes Research and member of Health...